Please login to the form below

Not currently logged in
Email:
Password:

Gilead's John Martin steps down as chief executive officer

He becomes executive chairman and is replaced as CEO by John Milligan 

Gilead John MartinGilead Sciences' John Martin has stepped down as chief executive officer, a role he had held since 1996, and moved to a new role as executive chairman.

His replacement as CEO is John Milligan who joined Gilead in 1990 as a research scientist and has since held several senior management positions at the company including chief financial officer.

Martin (pictured above) started at Gilead in 1990 as vice president for research and development and has 40 years of pharmaceutical and management expertise, during which he spent time in several leadership positions at Bristol-Myers Squibb and Syntex.

He was made chairman of Gilead's board in 2008 and will now transition from CEO and chair to executive chairman over the next six weeks.

John Cogan, Gilead's lead independent director, said: “John Martin has led Gilead as chief executive officer for the past 20 years, and under his stewardship, the company has developed and delivered therapeutic advancements to millions of people around the world.

“His legacy is clear - and the vision he has set will continue with his contributions as executive chairman.”

Gilead John MilliganTaking the reins from Martin at the California-based biopharmaceutical company is John Milligan (pictured left), who currently serves as its president and chief operating officer.

Milligan will become Gilead's chief executive officer on 10 March, when he will also join the firm's board of directors.

John Martin said: “Over the past 25 years, John Milligan has distinguished himself as an exceptional leader, serving in diverse management roles and overseeing multiple phases of growth and expansion into new therapeutic areas and geographies.

“The board of directors and I are confident in his ability to lead Gilead into the future.”

3rd February 2016

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

Pandemic preparedness
The pandemic preparedness paradox
Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...
Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...

Infographics